Grundlæggende statistik
| LEI | 5493005UQEY3UCKO3G18 |
| CIK | 1076167 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Adolor Corp
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| February 14, 2012 |
ADAGE CAPITAL PARTNERS GP, L.L.C. - ADOLOR CORPORATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1 )* Adolor Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 00724X102 (CUSIP Number) December 31, 2011 (Date of event which requires f |
|
| January 4, 2012 |
SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR SECTION 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6) ADOLOR CORPORATION (Name of Subject Company (Issuer)) FRD ACQUISITION CORPORATION CUBIST PHARMACEUTICALS, INC. (Names of Filing Persons (Offerors)) Common Stock, par value $0.0001 per share (Ti |
|
| November 29, 2011 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM November 29, 2011 VIA EDGAR Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549-3628 Attn: David L. Orlic Re: Adolor Corporation Amendment No.4 to Schedule TO-T filed by Cubist Pharmaceuticals, Inc. and FRD Acquisition Corporation Filed November 18, 2011 File No. 005-60253 Dear M |
|
| November 18, 2011 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM November 18, 2011 VIA EDGAR Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549-3628 Attn: David L. Orlic Re: Adolor Corporation Schedule TO-T filed by Cubist Pharmaceuticals, Inc. and FRD Acquisition Corporation Filed November 7, 2011 File No. 005-60253 Dear Mr. Orlic: On behalf |
|
| November 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR SECTION 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) ADOLOR CORPORATION (Name of Subject Company (Issuer)) FRD ACQUISITION CORPORATION CUBIST PHARMACEUTICALS, INC. (Names of Filing Persons (Offerors)) Common Stock, par value $0.0001 per share (Ti |
